Wegovy: The pill contains the same active ingredient as the injectionsemaglutide, a peptide-based drug
About that whole Shortage thing The interesting dynamic at play here isHims doesnt share investor concerns around the massive business risk associated with compounding GLP-1s during a shortage and capitalizing on a technicality
This is good news for those on Wegovy, as a recent study found that Semaglutide appears to improve cardiac remodelling
So if you, say, went from using up a whole Ozempic pen (which costs just shy of $1,000 without a prescription) once a month to using up a whole pen once every two months, that could save you $6,000 in a year
your clinician will discuss potential benefits, risks, and alternatives
[17] The FDA issued a safety communication in October 2023 warning against the use of probiotic products in preterm infants due to the risk of invasive infection